Ceapro Inc. (CZO.V) Research

Ceapro Inc. is a biotechnology firm dedicated to creating and distributing health and wellness solutions, alongside associated technologies, all derived from botanical extracts. Its operations span across the United States, Germany, China, Canada, and various other international markets. The company's activities are divided into two primary divisions: Active Ingredient Product Technology and Cosmeceuticals. Within the Active Ingredient Product Technology division, Ceapro focuses on pioneering unique extraction methods. These methods are then employed for the synthesis, refinement, and market introduction of potent compounds like oat beta glucan and avenanthramides, which are sourced from oats and other sustainable plant materials for the healthcare and beauty sectors. Conversely, the Cosmeceutical division concentrates on crafting and selling anti-aging products, formulated using natural active ingredients. These offerings reach consumers directly, primarily via online platforms, as well as through a curated selection of natural product retailers. Established in 1997, the company maintains its corporate headquarters in Edmonton, Canada.

Open Ceapro Inc. (CZO.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.